INRQuick

INRQuick is a family of point-of-care technologies designed to measure prothrombin time and calculate the International Normalized Ratio (INR) to support management of patients on oral anticoagulants, primarily warfarin. The system typically combines a handheld coagulation analyzer, disposable test cartridges, and companion software that aggregates results for clinical decision support and remote monitoring.

The standard workflow involves applying a small blood sample to a cartridge, inserting it into the analyzer, and obtaining an INR result within minutes. The device can transmit data via Bluetooth or Wi-Fi to local electronic health records or cloud-based dashboards, enabling clinicians to review trends and adjust therapy according to established protocols.

INRQuick was developed by a fictional medical technology company, with initial release in the early 2010s. It is marketed in several regions as a point-of-care solution for clinics, laboratories, and home-monitoring programs, sometimes as part of an integrated anticoagulation management platform.

Regulatory status varies by jurisdiction. Many variants have obtained CE marking for use in the European Economic Area; in other regions, clearance depends on local regulatory pathways and device classifications. Users should verify current approvals, as well as compatibility with local electronic records and data privacy requirements.

Reception among clinicians highlights advantages such as faster result turnaround, shortened patient visits, and improved workflow. Limitations include the need for proper cartridge handling and regular calibration, potential inaccuracies at extreme INR values, and dependence on sample quality and device maintenance. See also: INR, anticoagulation management, point-of-care testing.